Betadex Sulfobutyl Ether Sodium powder for Injectable and Parenteral Formulations, SBECD is widely used in the development of modern drugs due to its unique ability to enhance the solubility and bioavailability of APIs. It is especially useful in the formulation of antiviral, antifungal, anticancer, and cardiovascular drugs.
Betadex Sulfobutyl Ether Sodium powder for Injectable and Parenteral Formulations
Betadex Sulfobutyl Ether Sodium (SBECD) is a highly purified, non-toxic, anionic cyclodextrin derivative specifically developed for parenteral drug delivery systems, including injectable, ophthalmic, and inhalation formulations. It plays a vital role in modern pharmaceutical formulations by enhancing the solubility, stability, and bioavailability of poorly water-soluble active pharmaceutical ingredients (APIs), without the toxicity risks associated with traditional solubilizers.
SBECD forms dynamic inclusion complexes with hydrophobic drug molecules, allowing for safer and more effective delivery—particularly in intravenous, intramuscular, and ocular routes. It is especially favored in hospital-use or critical care formulations where excipient safety and performance are paramount.
Manufactured by Xi’an Deli Biochemical Industry Co., Ltd., our product meets USP and EP standards, and is backed by over two decades of expertise in cyclodextrin manufacturing.
Widely used in antiviral, antifungal, anticancer, and analgesic injectable drugs
Betadex Sulfobutyl Ether Sodium powder for Injectable and Parenteral Formulations, SBECD is widely used in the development of modern drugs due to its unique ability to enhance the solubility and bioavailability of APIs. It is especially useful in the formulation of antiviral, antifungal, anticancer, and cardiovascular drugs.
If you're interested in receiving a quotation, COA, or placing a trial order, please get in touch:
Email: xadl@xadl.com
Company: Xi’an Deli Biochemical Industry Co., Ltd.
